1,000 patients treated with OssDesign spinal bone graft

OssDesign’s Catalyst nanosynthetic bone graft has been used in 1,000 patients, the medtech company said May 9.

Advertisement

In January, the comapny reached 500 cases with Catalyst, according to a news release. It’s designed for spinal fusions and is made of a proprietary nanocrystalline structure that’s resorbed and replaced over time.

The bone graft was launched in the U.S. in August 2021.

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.